Pembrolizumab (pembro) in microsatellite instability-high (MSI-H) advanced gastric/gastroesophageal junction (G/GEJ) cancer by line of therapy
| dc.contributor.author | Van Cutsem, Eric | |
| dc.contributor.author | Chao, Joseph | |
| dc.contributor.author | Fuchs, Charles S. | |
| dc.contributor.author | Shitara, Kohei | |
| dc.contributor.author | Tabernero, Josep | |
| dc.contributor.author | Muro, Kei | |
| dc.contributor.author | Bang, Yung-Jue | |
| dc.contributor.author | De Vita, Ferdinando | |
| dc.contributor.author | Landers, Greg A. | |
| dc.contributor.author | Yen, Chia-Jui | |
| dc.contributor.author | Chau, Ian | |
| dc.contributor.author | Elme, Anneli | |
| dc.contributor.author | Lee, Jeeyun | |
| dc.contributor.author | Ozguroglu, Mustafa | |
| dc.contributor.author | Catenacci, Daniel V. T. | |
| dc.contributor.author | Li, Xiaodong | |
| dc.contributor.author | Shih, Chie-Schin | |
| dc.contributor.author | Shah, Sukrut | |
| dc.contributor.author | Bhagia, Pooja | |
| dc.contributor.author | Wainberg, Zev A. | |
| dc.date.accessioned | 2021-03-03T20:29:41Z | |
| dc.date.available | 2021-03-03T20:29:41Z | |
| dc.identifier.citation | Chao J., Fuchs C. S. , Shitara K., Tabernero J., Muro K., Van Cutsem E., Bang Y., De Vita F., Landers G. A. , Yen C., et al., "Pembrolizumab (pembro) in microsatellite instability-high (MSI-H) advanced gastric/gastroesophageal junction (G/GEJ) cancer by line of therapy", Gastrointestinal Cancers Symposium of the American-Society-of-Clinical-Oncology, San-Francisco, Kostarika, 23 - 25 Ocak 2020, cilt.38 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_5a318671-399c-4bdf-b18f-54cc87fe65db | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/63407 | |
| dc.language.iso | eng | |
| dc.subject | İç Hastalıkları | |
| dc.subject | ONKOLOJİ | |
| dc.subject | Klinik Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Tıp | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | Onkoloji | |
| dc.title | Pembrolizumab (pembro) in microsatellite instability-high (MSI-H) advanced gastric/gastroesophageal junction (G/GEJ) cancer by line of therapy | |
| dc.type | Bildiri | |
| dc.contributor.department | , , | |
| dc.identifier.volume | 38 | |
| dc.contributor.firstauthorID | 2277906 |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||
This item appears in the following Collection(s)
-
Bildiri [64839]
